The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients.

Ponti G., Maccaferri M., Manfredini M., Kaleci S., Mandrioli M., Pellacani G., ...More

Clinica chimica acta; international journal of clinical chemistry, vol.479, pp.14-19, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 479
  • Publication Date: 2018
  • Doi Number: 10.1016/j.cca.2018.01.007
  • Journal Name: Clinica chimica acta; international journal of clinical chemistry
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.14-19
  • Keywords: Cell-free fDNA, NanoDrop, Spectrophotometry, Fluorimetry, Qubit, qPCR, Malignant melanoma, Prostate cancer, Laboratory biomarkers, Circulating free tumor DNA, Tumor marker, BLOOD
  • Akdeniz University Affiliated: Yes


Background: Circulating cell-free tumor DNA (cfDNA) is of crucial interest in oncology. cfDNA constitutes a potential prognostic and therapeutic marker for different solid tumors and can be used in the diagnostic and therapeutic management of cancer patients for which nowadays there are no valid laboratory markers. In the present study, the quality and quantity of the cfDNA were assessed by different quantification procedures, in order to identify the potential applications of these techniques in the preliminary cfDNA quantification.